ABSTRACT
Aims To evaluate whether Cue-Induced Retrieval and Reconsolidation with Episodic Future Thinking (CIREF), which combines personalized drug-cue retrieval with structured future-oriented processing, produces greater changes in craving and delay discounting than a recent-past episodic active control in individuals with opioid use disorder receiving methadone maintenance treatment.
Design Multicentre, two-arm, parallel-group randomized controlled pilot trial with per-protocol analyses.
Setting Two outpatient addiction treatment and rehabilitation centres in Tehran, Iran.
Participants Thirty participants with opioid use disorder receiving methadone maintenance treatment were randomized to CIREF or Episodic Recent Thinking (ERT; n = 15 per group). Twenty-eight completed the intervention and were included in the analyses (n = 14 per group).
Intervention and comparator Participants completed one screening, baseline, and personalized cue-development session followed by three 75-minute intervention sessions. CIREF combined personalized drug-cue retrieval with future-oriented simulation, prediction, intention, and planning. ERT was structurally matched but anchored episodic processing to the recent past.
Measurements Primary craving outcomes comprised the three Desire for Drug Questionnaire (DDQ) subscales assessing session-level phasic/current craving immediately before and after each intervention session and the four Obsessive–Compulsive Drug Use Scale (OCDUS) subscales assessing tonic craving before and after the intervention period. The secondary outcome was Monetary Choice Questionnaire (MCQ) log(k), with more negative values indicating less steep delay discounting.
Findings After Holm correction across the three DDQ subscales, Group × Occasion interactions indicated greater reductions with CIREF for Desire and Intention to Drug Use, FGG(1.23, 32.09) = 24.37, pHolm < .001, η²p = .484, and Negative Reinforcement, FGG(1.35, 35.23) = 17.67, pHolm < .001, η²p = .405, but not Drug Abuse Control (pHolm = .172). After Holm correction across the four OCDUS subscales, only Desire and Mental Preoccupation with Drugs showed a significant Group × Time interaction, F(1, 26) = 12.35, pHolm = .007, η²p = .322; the remaining subscales were not significant (adjusted ps ≥ .177). MCQ log(k) showed a Group × Time interaction, F(1, 26) = 7.18, p = .013, η²p = .217; mean log(k) changed from −1.22 (0.36) to −1.80 (0.55) in CIREF and from −1.39 (0.32) to −1.44 (0.44) in ERT.
Conclusions In this small pilot sample, the future-oriented retrieval-based intervention produced greater changes than the recent-past active control in two dimensions of session-level phasic craving, one dimension of tonic craving, and monetary delay discounting. The results are preliminary and do not establish memory reconsolidation or effects on relapse or longer-term clinical outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
IRCT: IRCT20210804052079N1 OSF: DOI: 10.17605/OSF.IO/GQTP7
Clinical Protocols
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethics Committees of the University of Tehran and the Institute for Cognitive Science Studies gave ethical approval for this work (Approval Code: IR.UT.IRICSS.REC.1400.011).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
De-identified participant-level data and supporting materials may be made available upon reasonable request after publication of the primary study results, subject to review for scientific appropriateness, ethical acceptability, participant confidentiality, and feasibility. Approved requesters may be required to enter into a data-use agreement. Direct identifiers and potentially identifying free-text information, including personalized drug-cue content, will not be shared. Study documentation, non-identifying study materials, analysis code, and publication-related supporting materials are publicly available through the Open Science Framework repository at https://osf.io/q6w9d/.
